HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Colucci, P. M. Articles by Rall, C. J. Search for Related Content PubMed PubMed Citation Articles by Colucci, P. M. Articles by Rall, C. J.

Colorectal Polyps

Department of Internal Medicine, Marshfield Clinic, Marshfield, Wisconsin

Steven H. Yale, MD

Department of Internal Medicine, Marshfield Clinic, Marshfield, Wisconsin

Christopher J. Rall, MD

Department of Gastroenterology, Marshfield Clinic, Marshfield, Wisconsin

REPRINT REQUESTS: Steven Yale, MD, Department of Internal Medicine, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449, Telephone: 715-387-5436, Fax: 715-389-3808, Email: yale.steven{at}marshfieldclinic.org

Key Words: Colon Polyp • Screening • Colorectal cancer

Describe the current general classification of colon polyps. Which features of an adenomatous polyp correlate with greater malignant potential?

Colorectal polyps are classified histologically as neoplastic or non-neoplastic (Table 1). The majority of polyps are small, non-neoplastic lesions that are found during screening or when procedures are performed for other diagnostic reasons (for example, a gastrointestinal bleed). The malignant potential and subsequent screening intervals are dependent on polyp type.

The adenoma-carcinoma sequence has traditionally been characterized as a uniform progression from normal mucosa, to adenoma, to carcinoma through an underlying homogenous carcinogenic pathway. The process of adenoma development is initiated when both copies of the adenomatous polyposis coli (APC) tumor suppressor gene are deactivated in a single epithelial cell. The consequent lack of the suppressor permits activation of oncogenes, including, but not limited to, p53 and k-ras. There is evidence, however, that colorectal carcinogenesis is a heterogeneous process involving more than one precursor lesion.

What are the current recommendations regarding colorectal cancer screening?

Several screening tests are available. No uniform consensus is available with respect to the best method of screening. Currently accepted screening modalities include annual fecal occult blood testing plus or minus sigmoidoscopy every 5 years, flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, or double-contrast barium enema every 5 years.

Evidence suggests that colonoscopic screening in asymptomatic adults can result in detection of advanced colonic neoplasms that other modalities would likely miss. There is evidence that colonoscopy has superior efficacy compared to double contrast barium enema as a method for screening for colorectal cancer. However, there is insufficient data available, at the present time, for the United States Preventive Task Force (USPTF) to make a recommendation regarding the most cost-effective method for screening. Professional organizations do agree that all asymptomatic, average risk adults 50 years or older should be screened.

How should malignant polyps be managed?

The histopathologic features and risk of surgical resection guide the management of malignant polyps. Complete excision during endoscopy is essential with submission in toto for pathological evaluation. Proper fixation and sectioning to facilitate accurate determination of depth of invasion, grade of differentiation, and completeness of excision are required. Favorable histopathologic and clinical prognostic features of malignant colorectal polyps are clearly defined (Table 2).

Factors that place patients at higher risk of developing metachronous adenomas include male gender, multiple polyps, polyps >2 cm, polyps with tubulovillous and villous histology at index polypectomy, or family history of colorectal cancer. High risk patients should undergo a first follow-up colonoscopic evaluation at three years and then every five years after the first negative exam.

In patients with malignant polyps that have poor prognostic features, the decision to proceed to surgical resection must be individualized. Generally speaking, the relative risk of surgical resection must be weighed against the patient’s risk of local recurrence or nodal metastases.

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Colucci, P. M. Articles by Rall, C. J. Search for Related Content PubMed PubMed Citation Articles by Colucci, P. M. Articles by Rall, C. J.